Juniper pharmaceuticals inc (JNP)
CashFlow / Quarterly
Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Class of Stock
Class of Stock
Series C Preferred Stock [Member]
Operating activities:
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,186

Net income (loss)

-

772

-

-

-

-1,441

9,614

248

-2,268

-1,643

-976

368

-906

18

770

3,744

-10

152

-876

1,718

2,657

1,242

2,631

388

1,942

4,954

-

-

-

-

Reconciliation of net loss to net cash used in operating activities:
Depreciation and amortization

621

590

585

593

591

484

464

469

477

489

409

472

507

523

528

515

501

448

543

162

106

108

201

248

186

4

46

34

40

46

Change in fair value of common stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-1

-70

-309

-316

-428

155

-205

-

-

-

-

-

-

-

-

Stock-based compensation expense

503

566

253

371

504

341

397

329

357

118

356

490

372

532

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Write-off of inventories

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

102

108

335

422

0

58

-58

58

Change in value of redeemable warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

2,721

Change in fair value of stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,065

-205

-6,259

-

-5,050

-2,797

5,058

Recognition of deferred income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34

8,461

8,428

Provision for sales returns

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-122

0

-100

0

305

11

41

Stock-based compensation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

182

164

-

65

167

106

30

149

168

319

164

145

304

200

Deferred tax liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

896

-184

-177

7

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-41

4

-1

0

-1

-4

0

0

0

-3

Changes in operating assets and liabilities:
Accounts receivable

2,389

3,799

-1,822

-501

2,252

-2,107

1,488

-777

-1,528

625

-198

1,564

1,486

-353

514

-1,829

-166

-224

321

-489

897

1,618

-2,084

623

1,554

-1,868

1,936

-5,975

6,066

-1,124

Due from related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-900

-1

59

26

-1,379

-

-

-

-

-

-

-

-

Inventories

-38

-8

430

683

-481

72

783

901

728

-414

641

-796

449

130

346

-693

1,144

-178

589

-592

344

-387

-977

-426

-269

1,633

292

620

107

375

Prepaid expenses and other current assets

658

-1,145

1,299

310

288

-48

218

-673

-15

406

-1,439

199

417

564

-179

-160

242

428

-1,986

852

-23

-282

780

-486

1

320

107

-124

-110

402

Other non-current assets

-

-

-

-

-

-

0

0

0

-18

72

22

0

-5

-

-

-

2

-36

-29

1

114

0

0

-423

-1

-0

-0

0

-19

Accounts payable

1,798

1,117

-714

1,702

558

-1,363

-1,251

963

-54

1,927

-1,457

569

306

-343

1,763

-1,954

-91

373

220

-273

396

-28

-1,599

27

-709

-173

391

-393

471

-2,564

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

331

-1,260

279

690

-605

-373

548

76

-761

179

260

9

-667

-591

-329

-329

-588

Accrued expenses and other

3,573

-1,675

-

633

704

-1,039

-

970

671

-1,287

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-12

-11

-

-

-9

-9

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-17

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

283

186

-1,306

239

716

806

-116

-370

170

1,349

-1,241

638

466

-901

-1,173

-120

177

-218

1,653

-64

-31

-65

90

-34

-34

-34

279

0

-154

0

Net cash used in operating activities

-

-1,101

-

-

-

-138

7,506

3,158

151

371

-2,964

2,111

138

-176

989

5,072

-16

884

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

709

-

2,595

269

-1,613

-450

4,633

-1,249

-4,273

Investing activities:
Purchases of property and equipment

2,217

875

436

1,000

884

520

1,308

1,054

482

720

493

690

357

168

506

306

437

799

275

136

98

13

0

-58

127

917

676

5

620

4

Proceeds from Sale of Property, Plant, and Equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-65

-

-120

-68

-976

-746

-15,037

2,479

-4

Financing activities:
Additions to short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

52

-

-

-

58

-

-

-

-

Net cash used in investing activities

-

-875

-

-

-

-520

-1,308

-1,054

-482

-720

-493

-690

-357

-168

-506

-306

-437

-799

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of common stock / exercise of options

20

1,387

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16

0

5

12

1

10

0

0

-

-

-

-

0

-0

598

2,043

Proceeds from equipment loans

-

-

-

-

0

1,501

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments on debt

136

138

133

126

1,064

79

51

53

65

57

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments to satisfy employee taxes due on vesting of restricted awards

0

60

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

653

Principal payments on notes payable

-

-

-

-

-

-

-

-

-

-

-

61

59

59

61

63

63

58

-

-

-

-

-

-

-

-

-

-

-

-

Payments for the purchase of treasury stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

8,509

-

-

-

-

-

-

-

-

-

-

-

-

Dividends paid

-

-

0

7

0

7

7

7

7

7

7

7

7

7

7

7

7

7

7

7

7

7

-

-

7

7

7

7

7

7

Net cash provided by financing activities

-

1,189

-

-

-

1,415

-58

-60

-72

-64

-89

-68

17

-66

-52

-70

-65

-8,562

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7

-

-35

-7

-7

-7

-7

465

2,689

Effect of exchange rate changes on cash and cash equivalents

-

26

-

-

-

8

-117

-48

-92

-18

0

-36

31

-51

-66

-54

30

5

-

-

-

-70

10

28

-28

34

-8

-22

5

18

Net (decrease) increase in cash and cash equivalents

-

-761

-

-

-

765

6,023

1,996

-495

-431

-3,546

1,317

-171

-461

365

4,642

-488

-8,472

1,898

-12,604

17,650

567

3,018

2,468

165

-2,562

-1,213

-10,433

1,700

-1,570

Supplemental cash flow information
Cash paid for interest

-

46

-

-

-

23

18

23

22

22

25

25

26

25

27

29

30

34

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

0

0

0

2

0

0

0

3

0

0

0

3

-

15

31

5

20

90

77

31

Supplemental noncash information
Purchases of equipment through accounts payable and accrued expenses

372

98

220

-227

112

215

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification of redeemable warrant liability to capital in excess of par value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

16,193